Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith Regan

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
BJU International|April 24, 2008
Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapySabina Signoretti, Meredith Regan, Michael Atkins
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Journal of the National Cancer Institute|April 5, 2014
ResponseJames M Rae, Brian Leyland-Jones, Meredith Regan
Mechanisms of Ageing and Development|November 24, 2001
What does it take to live to 100?Thomas Perls, Robin Levenson, Meredith Regan, et al.
Journal of the National Cancer Institute|March 28, 2015
Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesJames M Rae, Brian Leyland-Jones, Meredith Regan, et al.
Cancer|April 30, 2009
Treatment selection for patients with metastatic renal cell carcinomaMichael B Atkins, Toni K Choueiri, Daniel Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancerDaniel Cho, Sabina Signoretti, Meredith Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancerJames M Rae, Meredith Regan, Brian Leyland-Jones, et al.
Radiology|May 25, 2006
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal modelsAndrew Hines-Peralta, Vikas Sukhatme, Meredith Regan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
BJU International|April 24, 2008
Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapySabina Signoretti, Meredith Regan, Michael Atkins
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinomaMichael B Atkins, Meredith Regan, David McDermott
Journal of the National Cancer Institute|April 5, 2014
ResponseJames M Rae, Brian Leyland-Jones, Meredith Regan
Mechanisms of Ageing and Development|November 24, 2001
What does it take to live to 100?Thomas Perls, Robin Levenson, Meredith Regan, et al.
Journal of the National Cancer Institute|March 28, 2015
Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesJames M Rae, Brian Leyland-Jones, Meredith Regan, et al.
Cancer|April 30, 2009
Treatment selection for patients with metastatic renal cell carcinomaMichael B Atkins, Toni K Choueiri, Daniel Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancerDaniel Cho, Sabina Signoretti, Meredith Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancerJames M Rae, Meredith Regan, Brian Leyland-Jones, et al.
Radiology|May 25, 2006
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal modelsAndrew Hines-Peralta, Vikas Sukhatme, Meredith Regan, et al.
Pageof 3